1. Home
  2. FSBW vs MRVI Comparison

FSBW vs MRVI Comparison

Compare FSBW & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • MRVI
  • Stock Information
  • Founded
  • FSBW 1936
  • MRVI 2014
  • Country
  • FSBW United States
  • MRVI United States
  • Employees
  • FSBW N/A
  • MRVI 560
  • Industry
  • FSBW Banks
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • MRVI Health Care
  • Exchange
  • FSBW Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • FSBW 324.8M
  • MRVI 350.1M
  • IPO Year
  • FSBW 2012
  • MRVI 2020
  • Fundamental
  • Price
  • FSBW $42.71
  • MRVI $2.42
  • Analyst Decision
  • FSBW Hold
  • MRVI Hold
  • Analyst Count
  • FSBW 1
  • MRVI 10
  • Target Price
  • FSBW $44.00
  • MRVI $5.84
  • AVG Volume (30 Days)
  • FSBW 17.5K
  • MRVI 1.5M
  • Earning Date
  • FSBW 10-21-2025
  • MRVI 08-11-2025
  • Dividend Yield
  • FSBW 2.62%
  • MRVI N/A
  • EPS Growth
  • FSBW N/A
  • MRVI N/A
  • EPS
  • FSBW 4.15
  • MRVI N/A
  • Revenue
  • FSBW $139,676,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • FSBW $9.62
  • MRVI N/A
  • Revenue Next Year
  • FSBW $5.35
  • MRVI $7.23
  • P/E Ratio
  • FSBW $10.28
  • MRVI N/A
  • Revenue Growth
  • FSBW 0.61
  • MRVI N/A
  • 52 Week Low
  • FSBW $34.61
  • MRVI $1.67
  • 52 Week High
  • FSBW $49.15
  • MRVI $9.60
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 61.80
  • MRVI 49.60
  • Support Level
  • FSBW $41.40
  • MRVI $2.28
  • Resistance Level
  • FSBW $42.89
  • MRVI $2.47
  • Average True Range (ATR)
  • FSBW 1.14
  • MRVI 0.14
  • MACD
  • FSBW 0.32
  • MRVI -0.01
  • Stochastic Oscillator
  • FSBW 95.42
  • MRVI 27.45

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: